Zhang, J., Sethuraman, J., Herrman, M., Murthy, P., Kaur, R., Wong, J. T. S., . . . Jakobovits, A. ADI-270: An armored allogeneic gamma delta T cell therapy designed to target CD70-expressing solid and hematologic malignancies. BMJ Publishing Group.
Chicago Style (17th ed.) CitationZhang, Jie, et al. ADI-270: An Armored Allogeneic Gamma Delta T Cell Therapy Designed to Target CD70-expressing Solid and Hematologic Malignancies. BMJ Publishing Group.
MLA (9th ed.) CitationZhang, Jie, et al. ADI-270: An Armored Allogeneic Gamma Delta T Cell Therapy Designed to Target CD70-expressing Solid and Hematologic Malignancies. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.